Sunlenca: payments to doctors
Payments that named Sunlenca as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $483K
- Providers
- 543
- Transactions
- 1,026
- Average per transaction
- $470
The per-transaction average — $470 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 543 providers the average total is $889, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Gilead | $482,551 | 100.0% |